Imprimis NJOF recalls

11 official recalls and safety alerts involving Imprimis NJOF since 2023-08, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Imprimis NJOF or the relevant agency.

2026-01-14
US
Drugs & medicalClass II
Imprimis NJOF, LLC recalls Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46…
Presence of particulate matter - Glass like particles.
FDA · DrugImprimis NJOF, LLCU.S NationwideOfficial notice →
2025-11-26
US
Drugs & medicalClass III
Imprimis NJOF, LLC recalls Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office Use Only, 5.5 mL…
Subpotent Drug
FDA · DrugImprimis NJOF, LLCUSA nationwideOfficial notice →
2025-07-30
US
Drugs & medicalClass III
Imprimis NJOF, LLC recalls Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton, Rx Only,…
Sub-Potent Drug: Subpotent assay results during stability testing.
FDA · DrugImprimis NJOF, LLCNationwide in the USAOfficial notice →
2025-04-09
US
Drugs & medicalClass III
Imprimis NJOF, LLC recalls Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5 mL fill in 15 mL bottle, Imprimis…
Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.
FDA · DrugImprimis NJOF, LLCFL and NYOfficial notice →
2024-06-19
US
Drugs & medicalClass II
Imprimis NJOF, LLC recalls Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantity: 20mL, Rx Only, Compounded by: Imprimis…
Lack of Assurance of Sterility
FDA · DrugImprimis NJOF, LLCUS NationwideOfficial notice →
2024-06-05
US
Drugs & medicalClass II
Imprimis NJOF, LLC recalls Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL and 0.4 mg/mL), Preservative-Free, 1mL Single-Use vials for Intraocular…
Lack of Assurance of Sterility
FDA · DrugImprimis NJOF, LLCNationwide within the United StatesOfficial notice →
2024-05-08
US
Drugs & medicalClass III
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx only, Imprimis NJOF, LLC 1705 Route 46…
Out of specification for assay
FDA · DrugImprimis NJOF, LLCNationwide within the United StatesOfficial notice →
US
Drugs & medicalClass II
Imprimis NJOF, LLC recalls Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC.…
Subpotent Drug
FDA · DrugImprimis NJOF, LLCU.S. NationwideOfficial notice →
2023-10-25
US
Drugs & medicalClass III
Imprimis NJOF, LLC recalls MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution Drops 1% - 0.5% - 2.5% - 0.5%, 5mL bottle,…
Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.
FDA · DrugImprimis NJOF, LLCProduct was distributed to physician's offices nationwide.Official notice →
2023-10-11
US
Drugs & medicalClass III
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC 71384-640-01 Not for resale.…
Subpotent: Failing Test Results for Epinephrine
FDA · DrugImprimis NJOF, LLCNationwideOfficial notice →
2023-08-30
US
Drugs & medicalClass III
Imprimis NJOF, LLC recalls Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B,…
Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.
FDA · DrugImprimis NJOF, LLCNationwide in the USOfficial notice →